• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Robert Sackstein, MD, PhD


  • Abdi R, Moore R, Sakai S, Donnelly CB, Mounayar M, Sackstein R.
    HCELL Expression on Murine MSC Licenses Pancreatotropism and Confers Durable Reversal of Autoimmune Diabetes in NOD Mice.
    Stem Cells. 2015 Jan 12.
  • Peter Y, Sen N, Levantini E, Keller S, Ingenito EP, Ciner A, Sackstein R, Shapiro SD.
    CD45/CD11b positive subsets of adult lung anchorage-independent cells harness epithelial stem cells in culture.
    Journal Of Tissue Engineering And Regenerative Medicine. 2012 May 15.
  • Sackstein R.
    Re: Ex Vivo Fucosylation Improves Human Cord Blood Engraftment in NOD-SCID IL-2Rγ Mice.
    Exp Hematol. 2012 Apr 13.
  • Sackstein R.
    Glycoengineering of HCELL, the Human Bone Marrow Homing Receptor: Sweetly Programming Cell Migration.
    Ann Biomed Eng. 2012 Apr;40(4):766-76.
  • Sackstein R.
    Engineering cellular trafficking via glycosyltransferase-programmed stereosubstitution.
    Ann N Y Acad Sci. 2012 Feb 21.
  • Jansen AJ, Josefsson EC, Rumjantseva V, Liu QP, Falet H, Bergmeier W, Cifuni SM, Sackstein R, von Andrian UH, Wagner DD, Hartwig JH, Hoffmeister KM.
    Desialylation accelerates platelet clearance after refrigeration and initiates GPIbα metalloproteinase-mediated cleavage in mice.
    Blood. 2012 Feb 2;119(5):1263-73.
  • Jacobs PP, Sackstein R.
    CD44 and HCELL: Preventing hematogenous metastasis at step 1.
    FEBS Lett. 2011 Oct 20;585(20):3148-58.
  • Merzaban JS, Burdick MM, Gadhoum SZ, Dagia NM, Chu JT, Fuhlbrigge RC, Sackstein R.
    Analysis of glycoprotein E-selectin ligands on human and mouse marrow cells enriched for hematopoietic stem/progenitor cells.
    Blood. 2011 Aug 18;118(7):1774-83.
  • Sackstein R.
    The biology of CD44 and HCELL in hematopoiesis: the 'step 2-bypass pathway' and other emerging perspectives.
    Curr Opin Hematol. 2011 Jul;18(4):239-48.
  • Thankamony SP, Sackstein R.
    Enforced hematopoietic cell E- and L-selectin ligand (HCELL) expression primes transendothelial migration of human mesenchymal stem cells.
    Proc Natl Acad Sci U S A. 2011 Feb 8;108(6):2258-63.
  • Chester R, Sackstein R.
    Embryonic stem cell-based therapeutics: balancing scientific progress and bioethics.
    Health Matrix Clevel. 2010;20(1):203-17.
  • Sackstein R.
    Directing stem cell trafficking via GPS.
    Methods Enzymol. 2010;479:93-105.
  • Sackstein R.
    Hitting the sweet spot for lymphoma.
    Blood. 2010 Jun 10;115(23):4626-7.
  • Lee JY, Buzney CD, Poznansky MC, Sackstein R.
    Dynamic alterations in chemokine gradients induce transendothelial shuttling of human T cells under physiologic shear conditions.
    J Leukoc Biol. 2009 Dec;86(6):1285-94.
  • Sackstein R.
    Glycosyltransferase-programmed stereosubstitution (GPS) to create HCELL: engineering a roadmap for cell migration.
    Immunol Rev. 2009 Jul;230(1):51-74. Review.
  • Sackstein R,Fuhlbrigge R.
    Western Blot Analysis of Adhesive Interactions under Fluid Shear Conditions: The Blot Rolling Assay.
    Methods Mol Biol. 2009;536:343-54.
  • Gadhoum SZ,Sackstein R.
    CD15 expression in human myeloid cell differentiation is regulated by sialidase activity.
    Nat Chem Biol. 2008 Dec;4(12):751-7.
  • Ngo HT, Leleu X, Lee J, Jia X, Melhem M, Runnels J, Moreau AS, Burwick N, Azab AK, Roccaro A, Azab F, Sacco A, Farag M, Sackstein R, Ghobrial IM.
    SDF-1/CXCR4 and VLA-4 interaction regulates homing in Waldenstrom Macroglobulinemia.
    Blood. 2008 Jul 1;112(1):150-8.
  • Resto VA, Burdick MM, Dagia NM, McCammon SD, Fennewald SM, Sackstein R.
    L-selectin-mediated lymphocyte-cancer cell interactions under low fluid shear conditions.
    J Biol Chem. 2008 Jun 6;283(23):15816-24.
  • Shaulov A, Yue S, Wang R, Joyce RM, Balk SP, Kim HT, Avigan DE, Uhl L, Sackstein R, Exley MA.
    Peripheral blood progenitor cell product contains Th1-biased noninvariant CD1d-reactive natural killer T cells: Implications for posttransplant survival.
    Exp Hematol. 2008 Apr;36(4):464-72.
  • Sackstein R, Merzaban JS, Cain DW, Dagia NM, Spencer JA, Lin CP, Wohlgemuth R.
    Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone.
    Nat Med. 2008 Feb;14(2):181-7.
  • Parmar K, Mauch P, Vergilio JA, Sackstein R, Down JD.
    Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia.
    Proc Natl Acad Sci U S A. 2007 Mar 27;104(13):5431-6.
  • Schreiber TH, Shinder V, Cain DW, Alon R, Sackstein R.
    Shear flow-dependent integration of apical and subendothelial chemokines in T-cell transmigration: implications for locomotion and the multistep paradigm.
    Blood. 2007 Feb 15;109(4):1381-6.
  • Dagia NM, Gadhoum SZ, Knoblauch CA, Spencer JA, Zamiri P, Lin CP, Sackstein R.
    G-CSF induces E-selectin ligand expression on human myeloid cells.
    Nat Med. 2006 Oct;12(10):1185-90.
  • Sackstein R, Fuhlbrigge R.
    The blot rolling assay: a method for identifying adhesion molecules mediating binding under shear conditions.
    Methods Mol Biol. 2006;341:217-26. Review.
  • Burdick MM, Chu JT, Godar S, Sackstein R.
    HCELL is the major E- and L-selectin ligand expressed on LS174T colon carcinoma cells.
    J Biol Chem. 2006 May 19;281(20):13899-905.
  • Fuhlbrigge RC, King SL, Sackstein R, Kupper TS.
    CD43 is a ligand for E-selectin on CLA+ human T cells.
    Blood. 2006 Feb 15;107(4):1421-6.
  • Hanley WD, Napier SL, Burdick MM, Schnaar RL, Sackstein R, Konstantopoulos K.
    Variant isoforms of CD44 are P- and L-selectin ligands on colon carcinoma cells.
    FASEB J. 2006 Feb;20(2):337-9.
  • Sackstein R.
    A Revision of Billingham's Tenets: The Central Role of Lymphocyte Migration in Acute Graft-versus-Host Disease.
    Biol Blood Marrow Transplant. 2006 Jan;12(1S1):2-8. Review.
  • Sackstein R.
    The lymphocyte homing receptors: gatekeepers of the multistep paradigm.
    Curr Opin Hematol. 2005 Nov;12(6):444-50.
  • Hanley WD, Burdick MM, Konstantopoulos K, Sackstein R.
    CD44 on LS174T colon carcinoma cells possesses E-selectin ligand activity.
    Cancer Res. 2005 Jul 1;65(13):5812-7.
  • Dey BR, McAfee S, Colby C, Cieply K, Caron M, Saidman S, Preffer F, Shaffer J, Tarbell N, Sackstein R, Sachs D, Sykes M, Spitzer TR.
    Anti-tumour response despite loss of donor chimaerism in patients treated with non-myeloablative conditioning and allogeneic stem cell transplantation.
    Br J Haematol. 2005 Feb;128(3):351-9.
  • Sackstein R.
    The bone marrow is akin to skin: HCELL and the biology of hematopoietic stem cell homing.
    J Invest Dermatol. 2004 May;122(5):1061-9.
  • Elfenbein GJ, Sackstein R.
    Primed marrow for autologous and allogeneic transplantation: a review comparing primed marrow to mobilized blood and steady-state marrow.
    Exp Hematol. 2004 Apr;32(4):327-39.
  • Elfenbein GJ, Sackstein R, Oblon DJ.
    Do G-CSF mobilized, peripheral blood-derived stem cells from healthy, HLA-identical donors really engraft more rapidly than do G-CSF primed, bone marrow-derived stem cells? No!.
    Blood Cells Mol Dis. 2004 Jan-Feb;32(1):106-11.
  • Dimitroff CJ, Kupper TS, Sackstein R.
    Prevention of leukocyte migration to inflamed skin with a novel fluorosugar modifier of cutaneous lymphocyte-associated antigen.
    J Clin Invest. 2003 Oct;112(7):1008-18.
  • Milinkovic M, Antin JH, Hergrueter CA, Underhill CB, Sackstein R.
    CD44-hyaluronic acid interactions mediate shear-resistant binding of lymphocytes to dermal endothelium in acute cutaneous GVHD.
    Blood. 2004 Jan 15;103(2):740-2.
  • Kraus AB, Shaffer J, Toh HC, Preffer F, Dombkowski D, Saidman S, Colby C, George R, McAfee S, Sackstein R, Dey B, Spitzer TR, Sykes M.
    Early host CD8 T-cell recovery and sensitized anti-donor interleukin-2-producing and cytotoxic T-cell responses associated with marrow graft rejection following nonmyeloablative allogeneic bone marrow transplantation.
    Exp Hematol. 2003 Jul;31(7):609-21.
  • Daly A, McAfee S, Dey B, Colby C, Schulte L, Yeap B, Sackstein R, Tarbell NJ, Sachs D, Sykes M, Spitzer TR.
    Nonmyeloablative bone marrow transplantation: Infectious complications in 65 recipients of HLA-identical and mismatched transplants.
    Biol Blood Marrow Transplant. 2003 Jun;9(6):373-82.
  • Dey BR, McAfee S, Colby C, Sackstein R, Saidman S, Tarbell N, Sachs DH, Sykes M, Spitzer TR.
    Impact of prophylactic donor leukocyte infusions on mixed chimerism, graft-versus-host disease, and antitumor response in patients with advanced hematologic malignancies treated with nonmyeloablative conditioning and allogeneic bone marrow transplantation.
    Biol Blood Marrow Transplant. 2003 May;9(5):320-9.
  • Toh HC, Spitzer TR, Preffer F, Alexander SI, McAfee S, Dombkowski D, Clark JS, Colby C, Saidman S, Sackstein R, Sykes M.
    Fluctuating lymphocyte chimerism, tolerance and anti-tumor response in a patient with refractory lymphoma receiving nonmyeloablative conditioning and a haploidentical related allogeneic bone marrow transplant.
    Cytokines Cell Mol Ther. 2002 Dec;7(2):43-7.
  • Bhler LH, Spitzer TR, Sykes M, Sachs DH, Delmonico FL, Tolkoff-Rubin N, Saidman SL, Sackstein R, McAfee S, Dey B, Colby C, Cosimi AB.
    Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stage renal disease.
    Transplantation. 2002 Nov 27;74(10):1405-9.
  • Bhler L, Kurilla-Mahon B, Chang Q, Abraham S, Alwayn IP, Appel JZ, Newman D, Awwad M, White-Scharf ME, Sackstein R, Sachs DH, Cooper DK, Down JD.
    Cryopreservation and mycophenolate therapy are detrimental to hematopoietic progenitor cells.
    Transplantation. 2002 Oct 27;74(8):1159-66.
  • Sackstein R, Messina JL, Elfenbein GJ.
    In vitro adherence of lymphocytes to dermal endothelium under shear stress: implications in pathobiology and steroid therapy of acute cutaneous GVHD.
    Blood. 2003 Jan 15;101(2):771-8.
  • Dimitroff CJ, Bernacki RJ, Sackstein R.
    Glycosylation-dependent inhibition of cutaneous lymphocyte-associated antigen expression: implications in modulating lymphocyte migration to skin.
    Blood. 2003 Jan 15;101(2):602-10.
  • Theodore PR, Simon AR, Warrens AN, Sackstein R, Sykes M.
    Porcine mononuclear cells adhere to human fibronectin independently of very late antigen-5: implications for donor-specific tolerance induction in xenotransplantation.
    Xenotransplantation. 2002 Jul;9(4):277-89.
  • Fuhlbrigge RC, King SL, Dimitroff CJ, Kupper TS, Sackstein R.
    Direct real-time observation of E- and P-selectin-mediated rolling on cutaneous lymphocyte-associated antigen immobilized on Western blots.
    J Immunol. 2002 Jun 1;168(11):5645-51.
  • Bhler L, Awwad M, Treter S, Chang Q, Basker M, Alwayn IP, Teranishi K, Ericsson T, Moran K, Harper D, Kurilla-Mahon B, Huang CA, Sackstein R, Sykes M, White-Scharf ME, Sachs DH, Down JD, Cooper DK.
    Pig hematopoietic cell chimerism in baboons conditioned with a nonmyeloablative regimen and CD154 blockade.
    Transplantation. 2002 Jan 15;73(1):12-22.
  • Dey BR, McAfee S, Sackstein R, Colby C, Saidman S, Weymouth D, Poliquin C, Vanderklish J, Sachs DH, Sykes M, Spitzer TR.
    Successful allogeneic stem cell transplantation with nonmyeloablative conditioning in patients with relapsed hematologic malignancy following autologous stem cell transplantation.
    Biol Blood Marrow Transplant. 2001;7(11):604-12.
  • Exley MA, Tahir SM, Cheng O, Shaulov A, Joyce R, Avigan D, Sackstein R, Balk SP.
    A major fraction of human bone marrow lymphocytes are Th2-like CD1d-reactive T cells that can suppress mixed lymphocyte responses.
    J Immunol. 2001 Nov 15;167(10):5531-4.
  • Dimitroff CJ, Lee JY, Schor KS, Sandmaier BM, Sackstein R.
    differential L-selectin binding activities of human hematopoietic cell L-selectin ligands, HCELL and PSGL-1.
    J Biol Chem. 2001 Dec 14;276(50):47623-31.
  • Bhler L, Goepfert C, Kitamura H, Basker M, Gojo S, Alwayn IP, Chang Q, Down JD, Tsai H, Wise R, Sachs DH, Cooper DK, Robson SC, Sackstein R.
    Porcine hematopoietic cell xenotransplantation in nonhuman primates is complicated by thrombotic microangiopathy.
    Bone Marrow Transplant. 2001 Jun;27(12):1227-36.
  • Gonzlez S, Sackstein R, Anderson RR, Rajadhyaksha M.
    Real-time evidence of in vivo leukocyte trafficking in human skin by reflectance confocal microscopy.
    J Invest Dermatol. 2001 Aug;117(2):384-6.
  • Alwayn IP, Buhler L, Appel JZ, Goepfert C, Csizmadia E, Correa L, Harper D, Kitamura H, Down J, Awwad M, Sackstein R, Cooper DK, Robson SC.
    Mechanisms of thrombotic microangiopathy following xenogeneic hematopoietic progenitor cell transplantation.
    Transplantation. 2001 Jun 15;71(11):1601-9.
  • Dimitroff CJ, Lee JY, Rafii S, Fuhlbrigge RC, Sackstein R.
    CD44 is a major E-selectin ligand on human hematopoietic progenitor cells.
    J Cell Biol. 2001 Jun 11;153(6):1277-86.
  • Dimitroff CJ, Lee JY, Fuhlbrigge RC, Sackstein R.
    A distinct glycoform of CD44 is an L-selectin ligand on human hematopoietic cells.
    Proc Natl Acad Sci U S A. 2000 Dec 5;97(25):13841-6.
  • Bhler L, Basker M, Alwayn IP, Goepfert C, Kitamura H, Kawai T, Gojo S, Kozlowski T, Ierino FL, Awwad M, Sachs DH, Sackstein R, Robson SC, Cooper DK.
    Coagulation and thrombotic disorders associated with pig organ and hematopoietic cell transplantation in nonhuman primates.
    Transplantation. 2000 Nov 15;70(9):1323-31.
  • Sackstein R, Dimitroff CJ.
    A hematopoietic cell L-selectin ligand that is distinct from PSGL-1 and displays N-glycan-dependent binding activity.
    Blood. 2000 Oct 15;96(8):2765-74.
  • Alwayn IP, Buhler L, Basker M, Goepfert C, Kawai T, Kozlowski T, Ierino F, Sachs DH, Sackstein R, Robson SC, Cooper DK.
    Coagulation/thrombotic disorders associated with organ and cell xenotransplantation.
    Transplant Proc. 2000 Aug;32(5):1099.
  • Gopfert C, Buhler L, Wise R, Basker M, Gojo S, Imai M, Alwayn I, Sachs DH, Sackstein R, Cooper DK, Robson SC.
    Von willebrand factor concentration, multimeric patterns, and cleaving protease activity in baboons undergoing xenogeneic peripheral blood stem cell transplantation.
    Transplant Proc. 2000 Aug;32(5):990.
  • Bhler L, Awwad M, Basker M, Gojo S, Thall A, Down JD, Sykes M, Andrews D, Sackstein R, White-Scharf ME, Sachs DH, Cooper DK.
    A nonmyeloablative regimen with CD40L blockade leads to humoral and cellular hyporesponsiveness to pig hematopoietic cells in baboons.
    Transplant Proc. 2000 Aug;32(5):1100.
  • Spitzer TR, McAfee S, Sackstein R, Colby C, Toh HC, Multani P, Saidman S, Weyouth DW, Preffer F, Poliquin C, Foley A, Cox B, Andrews D, Sachs DH, Sykes M.
    Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies.
    Biol Blood Marrow Transplant. 2000;6(3A):309-20.
  • Sackstein R.
    Adoptive Immunotherapy: The Magic Bullet of Cancer Therapy?.
    Cancer Control. 1994 Jan;1(1):65-66.
  • Bhler L, Awwad M, Basker M, Gojo S, Watts A, Treter S, Nash K, Oravec G, Chang Q, Thall A, Down JD, Sykes M, Andrews D, Sackstein R, White-Scharf ME, Sachs DH, Cooper DK.
    High-dose porcine hematopoietic cell transplantation combined with CD40 ligand blockade in baboons prevents an induced anti-pig humoral response.
    Transplantation. 2000 Jun 15;69(11):2296-304.
  • Toh HC, McAfee SL, Sackstein R, Multani P, Cox BF, Garcia-Carbonero R, Colby C, Spitzer TR.
    High-dose cyclophosphamide + carboplatin and interleukin-2 (IL-2) activated autologous stem cell transplantation followed by maintenance IL-2 therapy in metastatic breast carcinoma - a phase II study.
    Bone Marrow Transplant. 2000 Jan;25(1):19-24.
  • Colby C, Chang Q, Fuchimoto Y, Ferrara V, Murphy M, Sackstein R, Spitzer TR, White-Scharf ME, Sachs DH.
    Cytokine-mobilized peripheral blood progenitor cells for allogeneic reconstitution of miniature swine.
    Transplantation. 2000 Jan 15;69(1):135-40.
  • Salgia R, Quackenbush E, Lin J, Souchkova N, Sattler M, Ewaniuk DS, Klucher KM, Daley GQ, Kraeft SK, Sackstein R, Alyea EP, von Andrian UH, Chen LB, Gutierrez-Ramos JC, Pendergast AM, Griffin JD.
    The BCR/ABL oncogene alters the chemotactic response to stromal-derived factor-1alpha.
    Blood. 1999 Dec 15;94(12):4233-46.
  • Colby C, McAfee S, Sackstein R, Finkelstein D, Fishman J, Spitzer T.
    A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation.
    Bone Marrow Transplant. 1999 Oct;24(8):897-902.
  • Toh HC, McAfee SL, Sackstein R, Cox BF, Colby C, Spitzer TR.
    Late onset veno-occlusive disease following high-dose chemotherapy and stem cell transplantation.
    Bone Marrow Transplant. 1999 Oct;24(8):891-5.
  • Spitzer TR, Delmonico F, Tolkoff-Rubin N, McAfee S, Sackstein R, Saidman S, Colby C, Sykes M, Sachs DH, Cosimi AB.
    Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: the induction of allograft tolerance through mixed lymphohematopoietic chimerism.
    Transplantation. 1999 Aug 27;68(4):480-4.
  • Sykes M, Preffer F, McAfee S, Saidman SL, Weymouth D, Andrews DM, Colby C, Sackstein R, Sachs DH, Spitzer TR.
    Mixed lymphohaemopoietic chimerism and graft-versus-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantation.
    Lancet. 1999 May 22;353(9166):1755-9.
  • Ballester OF, Tummala R, Janssen WE, Fields KK, Hiemenz JW, Goldstein SC, Perkins JB, Sullivan DM, Rosen R, Sackstein R, Zorsky P, Saez R, Elfenbein GJ.
    High-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with multiple myeloma and renal insufficiency.
    Bone Marrow Transplant. 1997 Oct;20(8):653-6.
  • Sackstein R, Fu L, Allen KL.
    A hematopoietic cell L-selectin ligand exhibits sulfate-independent binding activity.
    Blood. 1997 Apr 15;89(8):2773-81.
  • Sackstein R.
    Expression of an L-selectin ligand on hematopoietic progenitor cells.
    Acta Haematol. 1997;97(1-2):22-8.
  • Wasik MA, Sackstein R, Novick D, Butmarc JR, Zhang Q, Vonderheid EC, Kadin ME.
    Cutaneous CD56+ large T-cell lymphoma associated with high serum concentration of IL-2.
    Hum Pathol. 1996 Jul;27(7):738-44.
  • Sackstein R.
    Lymphocyte migration following bone marrow transplantation.
    Ann N Y Acad Sci. 1995 Dec 29;770:177-88.
  • Sackstein R.
    Physiologic basis of steroid-induced immunosuppression. Effects on lymphocyte migration to lymph nodes.
    J Fla Med Assoc. 1995 Sep;82(9):613-5.
  • Sackstein R, Meng L, Xu XM, Chin YH.
    Evidence of post-transcriptional regulation of L-selectin gene expression in rat lymphoid cells.
    Immunology. 1995 Jun;85(2):198-204.
  • Sackstein R, Borenstein M.
    The effects of corticosteroids on lymphocyte recirculation in humans: analysis of the mechanism of impaired lymphocyte migration to lymph node following methylprednisolone administration.
    J Investig Med. 1995 Feb;43(1):68-77.
  • Oxley SM, Sackstein R.
    Detection of an L-selectin ligand on a hematopoietic progenitor cell line.
    Blood. 1994 Nov 15;84(10):3299-306.
  • Sackstein R.
    Effects of methylprednisolone administration on lymphocyte LECAM-1, CD44, and LFA-1 expression. Implications for steroid-induced lymphopenia.
    Ann N Y Acad Sci. 1993 Nov 30;696:417-9.
  • Sackstein R.
    Physiologic migration of lymphocytes to lymph nodes following bone marrow transplantation: role in immune recovery.
    Semin Oncol. 1993 Oct;20(5 Suppl 6):34-9.
  • Chin YH, Sackstein R, Cai JP.
    Lymphocyte-homing receptors and preferential migration pathways.
    Proc Soc Exp Biol Med. 1991 Apr;196(4):374-80.
  • Chin YH, Falanga V, Streilein JW, Sackstein R.
    Lymphocyte recognition of psoriatic endothelium: evidence for a tissue-specific receptor/ligand interaction.
    J Invest Dermatol. 1989 Aug;93(2 Suppl):82S-87S.
  • Sackstein R, Falanga V, Streilein JW, Chin YH.
    Lymphocyte adhesion to psoriatic dermal endothelium is mediated by a tissue-specific receptor/ligand interaction.
    J Invest Dermatol. 1988 Nov;91(5):423-8.
  • Chin YH, Falanga V, Streilein JW, Sackstein R.
    Specific lymphocyte-endothelial cell interactions regulate migration into lymph nodes, Peyer's patches, and skin.
    Reg Immunol. 1988 Jul-Aug;1(1):78-83.
  • Whitehead AS, Sackstein R.
    Molecular biology of the human and mouse MHC class III genes: phylogenetic conservation, genetics and regulation of expression.
    Immunol Rev. 1985 Oct;87:185-208.
  • Sackstein R, Colten HR.
    Molecular regulation of MHC class III (C4 and factor B) gene expression in mouse peritoneal macrophages.
    J Immunol. 1984 Sep;133(3):1618-26.
  • Chaplin DD, Sackstein R, Perlmutter DH, Weis JH, Kruse TA, Coligan J, Colten HR, Seidman JG.
    Expression of hemolytically active murine fourth component of complement in transfected L cells.
    Cell. 1984 Jun;37(2):569-76.
  • Sackstein R, Roos MH, Dmant P, Colten HR.
    Subdivision of the S region of the mouse major histocompatibility complex by identification of genomic polymorphisms of the class III genes.
    Immunogenetics. 1984;20(3):321-30.
  • Sackstein R, Colten HR, Woods DE.
    Phylogenetic conservation of a class III major histocompatibility complex antigen, factor B. Isolation and nucleotide sequencing of mouse factor B cDNA clones.
    J Biol Chem. 1983 Dec 10;258(23):14693-7.